Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse
Clinical trial NCT03229382 · TERMINATED
Trial details
- NCT number
- NCT03229382
- Sponsor
- Polish Lymphoma Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2020-01-31
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.